These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11531988)

  • 41. A simple method to reduce infection of ventriculoperitoneal shunts.
    Rehman AU; Rehman TU; Bashir HH; Gupta V
    J Neurosurg Pediatr; 2010 Jun; 5(6):569-72. PubMed ID: 20515328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period.
    Sacar S; Turgut H; Toprak S; Cirak B; Coskun E; Yilmaz O; Tekin K
    BMC Infect Dis; 2006 Mar; 6():43. PubMed ID: 16524475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurosurgical material-associated infections].
    Zarrouk V
    Rev Prat; 2014 May; 64(5):660-1, 663-4. PubMed ID: 24923053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of ventriculoperitoneal shunt infection on Ga-67 citrate scintigraphy.
    Sun SS; Chuang FJ; Chiu KL; Kao CH
    Clin Nucl Med; 2002 Sep; 27(9):666. PubMed ID: 12192290
    [No Abstract]   [Full Text] [Related]  

  • 45. Staphylococcus lugdunensis endocarditis after angiography.
    Polenakovik H; Herchline T; Bacheller C; Bernstein J
    Mayo Clin Proc; 2000 Jun; 75(6):656-7. PubMed ID: 10852432
    [No Abstract]   [Full Text] [Related]  

  • 46. Ogilvie's syndrome following ventriculoperitoneal shunt surgery for normal pressure hydrocephalus.
    Katzir M; Abeshaus S; Attia M; Zaaroor M
    Acta Neurochir (Wien); 2014 Apr; 156(4):787-8. PubMed ID: 24510002
    [No Abstract]   [Full Text] [Related]  

  • 47. Bacterial peritonitis in patients with ventriculoperitoneal shunt.
    Tchirkow G; Verhagen AD
    J Pediatr Surg; 1979 Apr; 14(2):182-4. PubMed ID: 458542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.
    McGirt MJ; Zaas A; Fuchs HE; George TM; Kaye K; Sexton DJ
    Clin Infect Dis; 2003 Apr; 36(7):858-62. PubMed ID: 12652386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic resistant infections with antibiotic-impregnated Bactiseal catheters for ventriculoperitoneal shunts.
    Demetriades AK; Bassi S
    Br J Neurosurg; 2011 Dec; 25(6):671-3. PubMed ID: 21707238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corpus Callosum Hyperintensity in Normal Pressure Hydrocephalus After Ventriculoperitoneal Shunt.
    Youn J; Kovacs GG; Kongkham P; Fasano A
    Neurology; 2021 Jun; 96(23):1096-1097. PubMed ID: 33893207
    [No Abstract]   [Full Text] [Related]  

  • 51. Early onset tension pneumocephalus following ventriculoperitoneal shunt insertion for normal pressure hydrocephalus: a case report.
    Barada W; Najjar M; Beydoun A
    Clin Neurol Neurosurg; 2009 Apr; 111(3):300-2. PubMed ID: 19185417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants and outcomes of ventriculoperitoneal shunt infections in Enugu, Nigeria.
    Uche EO; Onyia E; Mezue UC; Okorie E; Ozor II; Chikani MC
    Pediatr Neurosurg; 2013; 49(2):75-80. PubMed ID: 24434896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
    Frank KL; Reichert EJ; Piper KE; Patel R
    Antimicrob Agents Chemother; 2007 Mar; 51(3):888-95. PubMed ID: 17158933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of cerebrospinal fluid shunt infections with teicoplanin.
    Fernández Guerrero ML; de Górgolas M; Fernández Roblas R; Campos JM
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1056-8. PubMed ID: 7889968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neonatal Staphylococcus lugdunensis urinary tract infection.
    Hayakawa I; Hataya H; Yamanouchi H; Sakakibara H; Terakawa T
    Pediatr Int; 2015 Aug; 57(4):783-5. PubMed ID: 26177232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vitro Activity of Linezolid, Daptomycin and N-acetylcysteine Agents on Staphylococcus Aureus Biofilms in the Ventriculoperitoneal Shunt Model.
    Kuruoglu T; Onger ME; Turan DB; Kuruoglu E
    Turk Neurosurg; 2019; 29(1):66-71. PubMed ID: 29582407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosomal rearrangements affecting biofilm production and antibiotic resistance in a Staphylococcus epidermidis strain causing shunt-associated ventriculitis.
    Ziebuhr W; Dietrich K; Trautmann M; Wilhelm M
    Int J Med Microbiol; 2000 Mar; 290(1):115-20. PubMed ID: 11043988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic susceptibility pattern and biofilm formation in coagulase negative staphylococci.
    Ayepola OO; Olasupo NA; Egwari LO; Schaumburg F
    J Infect Dev Ctries; 2014 Dec; 8(12):1643-5. PubMed ID: 25500666
    [No Abstract]   [Full Text] [Related]  

  • 59. Spondylodiscitis due to Staphylococcus lugdunensis.
    Guttmann G; Garazi S; Van Linthoudt D
    Clin Exp Rheumatol; 2000; 18(2):271-2. PubMed ID: 10812514
    [No Abstract]   [Full Text] [Related]  

  • 60. Different Behavior and Response of Staphylococcus Epidermidis and Streptococcus Pneumoniae to a Ventriculoperitoneal Shunt: An in vitro Study.
    Heidari V; Habibi Z; Hojjati Marvasti A; Ebrahim Soltani Z; Naderian N; Tanzifi P; Nejat F
    Pediatr Neurosurg; 2017; 52(4):257-260. PubMed ID: 28704823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.